Evidence map›Paper›PMID 36446791›Full record

ArticleNature communications2022

HSP90-CDC37-PP5 forms a structural platform for kinase dephosphorylation.

Jasmeen Oberoi, Xavi Aran Guiu, Emily A Outwin, Pascale Schellenberger, Theodoros I Roumeliotis, Jyoti S Choudhary, Laurence H Pearl

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jasmeen OberoiGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton, BN1 9RQ, UK.ORCID 0000-0001-8216-3898
Xavi Aran GuiuGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton, BN1 9RQ, UK.ORCID 0000-0003-4683-6340
Emily A OutwinGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton, BN1 9RQ, UK.
Pascale SchellenbergerElectron Microscopy Imaging centre, School of Life Sciences, University of Sussex, Falmer, BN1 9QG, UK.
Theodoros I RoumeliotisInstitute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK.ORCID 0000-0002-3354-5643
Jyoti S ChoudharyInstitute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK.ORCID 0000-0003-0881-5477
Laurence H PearlGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton, BN1 9RQ, UK. laurence.pearl@sussex.ac.uk.ORCID 0000-0002-6910-1809
University of Sussex · GBInstitute of Cancer Research · GB

Funding

Cancer Research UK C309/A25144Wellcome TrustWellcome Trust 210719/Z/18/Z
6 · The paper itself

Abstract

Activation of client protein kinases by the HSP90 molecular chaperone system is affected by phosphorylation at multiple sites on HSP90, the kinase-specific co-chaperone CDC37, and the kinase client itself. Removal of regulatory phosphorylation from client kinases and their release from the HSP90-CDC37 system depends on the Ser/Thr phosphatase PP5, which associates with HSP90 via its N-terminal TPR domain. Here, we present the cryoEM structure of the oncogenic protein kinase client BRAF

Indexed as

HSP90 Heat-Shock ProteinsCell Cycle ProteinsChaperoninsGlycoproteinsHumansMolecular ChaperonesPhosphoric Monoester HydrolasesProteomicsProto-Oncogene Proteins B-rafCDC37 protein, humanCell Cycle ProteinsChaperoninsGlycoproteinsHSP90 Heat-Shock ProteinsMolecular ChaperonesPhosphoric Monoester HydrolasesProto-Oncogene Proteins B-raftissue-factor-pathway inhibitor 2

Identifiers

PMID36446791
PMCPMC9709061
OpenAlexW4310599310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.